Clinical trial
Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
NCT00294346 · Avera Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00294346 |
|---|---|
| Title | Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder |
| Official title | A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Social Anxiety Disorder |
| Lead sponsor | Avera Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | AV608 |
| Enrollment | 180 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 22, 2006 |
| Last update posted | Feb 25, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: